Pages that link to "Q24682910"
Jump to navigation
Jump to search
The following pages link to From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells (Q24682910):
Displaying 50 items.
- The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator (Q22010240) (← links)
- PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression (Q22011032) (← links)
- Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells (Q22254244) (← links)
- Identification of guanine nucleotide exchange factors (GEFs) for the Rap1 GTPase. Regulation of MR-GEF by M-Ras-GTP interaction (Q22254750) (← links)
- Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cells (Q24291571) (← links)
- Identification of human male germ cell-associated kinase, a kinase transcriptionally activated by androgen in prostate cancer cells (Q24300367) (← links)
- Supervillin associates with androgen receptor and modulates its transcriptional activity (Q24530343) (← links)
- Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations (Q24537137) (← links)
- Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation (Q24631073) (← links)
- Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor (Q24631156) (← links)
- EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance (Q24646417) (← links)
- Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling (Q24650935) (← links)
- Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells (Q24675586) (← links)
- Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach (Q24685731) (← links)
- Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase (Q24746249) (← links)
- Transcriptional programs activated by exposure of human prostate cancer cells to androgen (Q24802648) (← links)
- Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation (Q24815477) (← links)
- Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism (Q26774456) (← links)
- Persistent androgen receptor addiction in castration-resistant prostate cancer (Q26777163) (← links)
- Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer (Q26795625) (← links)
- Androgen deprivation of prostate cancer: Leading to a therapeutic dead end (Q26799813) (← links)
- Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor (Q26863333) (← links)
- A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth (Q28116222) (← links)
- From androgen receptor to the general transcription factor TFIIH. Identification of cdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator (Q28139675) (← links)
- Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways (Q28212733) (← links)
- Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells (Q28265036) (← links)
- Mechanisms of disease: the role of heat-shock protein 90 in genitourinary malignancy (Q28272747) (← links)
- Sustained proliferation in cancer: Mechanisms and novel therapeutic targets (Q28396388) (← links)
- Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase (Q28511501) (← links)
- Pterostilbene-isothiocyanate conjugate suppresses growth of prostate cancer cells irrespective of androgen receptor status (Q28541923) (← links)
- A novel steroid receptor co-activator protein (SRAP) as an alternative form of steroid receptor RNA-activator gene: expression in prostate cancer cells and enhancement of androgen receptor activity (Q28574016) (← links)
- Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen (Q28727939) (← links)
- The development of androgen-independent prostate cancer (Q29615650) (← links)
- The focal adhesion protein vinexin alpha regulates the phosphorylation and activity of estrogen receptor alpha (Q30164406) (← links)
- Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells (Q30306146) (← links)
- Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites (Q30309352) (← links)
- Androgen receptor phosphorylation: biological context and functional consequences (Q30394055) (← links)
- Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator (Q30816464) (← links)
- Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors (Q31081891) (← links)
- Tyrphostin [correction of Tryphostin] AG879, a tyrosine kinase inhibitor: prevention of transcriptional activation of the electrophile and the aromatic hydrocarbon response elements (Q31860006) (← links)
- Molecular staging of prostate cancer in the year 2007. (Q33276580) (← links)
- Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer (Q33339736) (← links)
- Characterization of SV-40 Tag rats as a model to study prostate cancer (Q33403060) (← links)
- Analysis of the molecular networks in androgen dependent and independent prostate cancer revealed fragile and robust subsystems (Q33529070) (← links)
- Minireview: Tipping the balance: ligand-independent activation of steroid receptors (Q33631775) (← links)
- Phosphorylation of steroidogenic factor 1 is mediated by cyclin-dependent kinase 7 (Q33643318) (← links)
- Mutation of the androgen receptor causes oncogenic transformation of the prostate (Q33732154) (← links)
- Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells (Q34001080) (← links)
- Preclinical and clinical studies with the multi-kinase inhibitor CEP-701 as treatment for prostate cancer demonstrate the inadequacy of PSA response as a primary endpoint (Q34013882) (← links)
- The role of HER2 in cancer therapy and targeted drug delivery (Q34054213) (← links)